Headquarters: Hangzhou, China
CNY as of July 1, 2023
|Company||Market Cap (USD)|
|Thermo Fisher Scientific||$199.03 B|
|Siemens Healthineers AG||$62.71 B|
|DexCom, Inc.||$49.13 B|
|Lonza Group Ltd||$43.73 B|
Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in China and internationally. It operates through Clinical Trial Solutions; and Clinical-Related and Laboratory Services. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting; clinical services in the areas of medical science, early clinical and late phase development, medical monitoring, project management, patient recruitment, and quality management system; and biometrics services covering data management, biostatistics, and statistical programming. It also provides integrated technology services, such as site management, pharmacovigilance, third party audit and training, medical imaging, clinical trial system solution, central laboratory, pre-clinical, and research hospital; medical device/ in vitro diagnostics (IVD) services comprising medical device testing, regulatory submission, clinical evaluation and trials, GMP certificate, EU MDR and IVDR preparation, and value added services; and post-marketing study, real world evidence, and vaccine clinical trial services. The company was incorporated in 2004 and is headquartered in Hangzhou, China.
Unlock the Power of Financial AI:
Try Disfold AI Free for 7 Days!